Evaluation of Safe Systemic Immunosuppression Created with Dexamethasone in Prevention of Capsular Contracture: A Glance to Distinct Perspectives with Toll-Like Receptors
The toll-like receptors (TLRs) stand at the interface of innate immune activation. We hypothesize to decrease the response of innate immunity activated by TLR4 by a safe, short-term, systemic immunosuppression.
Two silicone block implants were placed into two dorsal subcutaneous pockets in 32 rats that were subdivided into four groups: The two study groups were the IV DEX group (single intravenous injection of dexamethasone 1 h before surgery) and the IV DEX + IP DEX group (in addition to a single intravenous injection of dexamethasone 1 h before surgery, intraperitoneal dexamethasone was administered for 10 days after surgery), and the two control groups were the untreated control group and the saline-treated control group. After 10 weeks, all animals were killed to determine capsular thickness, inflammatory cell density, presence of pseudoepitheliomatous hyperplasia, edema, necrosis, vascularization, TLR4 expression and myofibroblast proliferation.
No significant difference was observed in any parameter between the untreated and saline-treated control groups (p > 0.05). Capsular thickness, myofibroblast proliferation, TLR4 expression density were statistically different among study groups compared to control (p < 0.05).
This study demonstrates the relationship between toll-like receptors and fibrous capsule after implant surgery. Decreasing the innate immunity by a safe, short-term perioperative systemic immunosuppression resulted in decreased TLR4 expression and myofibroblast differentiation which could be a new research field in profibrotic pathophysiology underlying breast capsule formation.
No Level Assigned
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
KeywordsCapsule formation Dexamethasone Implant Toll-like receptor
All authors (OC, KO, AD, HO, OO) confirmed no funding supporting the work and no statement of financial interest and no conflict of interest. All authors bear the responsibility of this letter.
- 1.American Society of Plastic Surgeons (2016) ASPS national clearinghouse of plastic surgery procedural statistics. https://www.plasticsurgery.org/documents/News/Statistics/2016/plastic-surgery-statistics-full-report-2016.pdf
- 6.Segreto F, Carotti S, Tosi D et al (2016) Toll-like receptor 4 expression in human breast implant capsules: localization and correlation with estrogen receptors. Plast Reconstr Surg 137:792–798. https://doi.org/10.1097/01.prs.0000479941.42174.f1 CrossRefPubMedGoogle Scholar
- 7.Mollen KP, Anand RJ, Tsung A et al (2006) Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26:430–437. https://doi.org/10.1097/01.shk.0000228797.41044.08 CrossRefPubMedGoogle Scholar
- 16.Prantl L, Schreml S, Fichtner-Feigl S et al (2007) Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg 120:275–284. https://doi.org/10.1097/01.prs.0000264398.85652.9a CrossRefPubMedGoogle Scholar
- 23.Isom C, Kapoor V, Wilson L et al (2007) Breast implant capsules are partially composed of bone marrow-derived cells. Ann Plast Surg 58:377–380. https://doi.org/10.1097/01.sap.0000243996.37786.4a CrossRefPubMedGoogle Scholar